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Abstract
Background: Micronutrient malnutrition has been associated with maternal depressive symptoms (MDS), but little
is known about the effects of preconceptional micronutrient supplementation. This paper examined the effects of
preconceptional micronutrient supplementation on MDS during pregnancy and postpartum.
Methods: We used data from a double-blind controlled trial (PRECONCEPT) in which 5011 Vietnamese women
were randomized to receive weekly supplements containing either a) multiple micronutrients (MM) b) iron and folic
acid (IFA) or c) folic acid (FA) until conception (n = 1813). Maternal mental health was assessed using the Center for
Epidemiologic Studies Depression Scale (CES-D) at baseline (preconception), and the Edinburgh Postnatal
Depression Scale (EPDS) during pregnancy and 3 months postpartum. Elevated MDS was defined as EPDS
score ≥ 4. All group comparisons were done using ANOVA or chi-square tests of proportions intention to treat and
per protocol analyses (women consumed supplements ≥26 weeks before conception). We also conducted stratified
analyses by preconception CES-D scores, underweight, or anemia status using generalized linear models.
Results: Baseline CES-D scores were similar across treatment groups. The proportion of women experiencing
elevated MDS was 11.3, 8.1 and 4.9% at first, second and third trimesters of pregnancy, respectively, and 3.6% at 3
mo postpartum. Mean EPDS scores at first (1.5 ± 2.7), second (1.1 ± 2.4), and third trimester of pregnancy (0.7 ± 2.0)
and early postpartum (0.6 ± 1.8) were low and did not differ by treatment group. However, among women in the
highest tertile of CES-D scores at preconception, mean EPDS scores in the first and second trimesters of pregnancy
were lower in the MM and IFA groups compared to FA only (P < 0.05).
Conclusions: Weekly preconceptional micronutrient supplements containing iron did not improve depression measures
relative to folic acid alone among all women, but may have benefitted women who were at risk for depression.
Trial registration: The trial was registered retrospectively at ClinicalTrials.Gov as NCT01665378 on August 13, 2012.
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Background
Strong evidence supports the importance of maternal
mental health for optimal child health, nutrition and
development [1–3]. Children exposed to maternal de-
pression during the first 1000 days of life may experi-
ence irreversible changes in their brain architecture
and/or persistent disruptions of their stress response
systems, resulting in increased risk for long-term
physical and psychological difficulties [4]. During
pregnancy, depression may affect child outcomes (in-
cluding behavior, socioemotional adjustment, and
emotion regulation) through altered placental func-
tion, epigenetic changes in the child, and stress re-
activity. During the postnatal period, maternal
depression may affect child outcomes through altered
mother–child interactions, environmental influences,
and social support [5]. Poor maternal mental health,
in particular maternal depression, is also a risk factor
for higher morbidity and growth faltering in young
children [6].
Research also suggests a relationship between nutri-
tion and mental health status [7, 8]. Several micronutri-
ents such as iron, zinc, folate, vitamin B-6, B-12,
calcium, selenium, and n-3 fatty acids have been linked
to maternal mental health and wellbeing [9, 10] How-
ever, much of the work to date has focused on the
postpartum period. For example, higher depressive
symptoms have been reported for women who were
anemic during the postpartum period compared with
non-anemic women [11]. Recent evidence from a ran-
domized, placebo-controlled trial conducted during
postpartum in South Africa demonstrated the benefits
of daily iron supplementation in reducing depressive
symptoms among anemic mothers [12]. In contrast, lit-
tle is known about the benefits of providing micronu-
trient supplements before and during pregnancy for
improving maternal mental health outcomes, indicating
the need for studies that evaluate the effects of nutri-
tion interventions during these critical periods. This is
particularly relevant in low-middle income countries
where the problems of maternal depression and poor
health and nutrition among women and children are
high and coexist [13–15].
We had the unique opportunity to include measures of
maternal mental health as a secondary outcome in the
PRECONCEPT study, a large randomized controlled trial
(RCT) evaluating the effects of preconceptional micronu-
trient interventions on birth outcomes in rural Vietnam
[16]. The objective of this paper was to examine the effects
of weekly micronutrient supplements containing multiple
micronutrients (MM), iron and folic acid (IFA) or only folic
acid (FA), when provided to women of reproductive age be-
fore conception, on maternal mental health outcomes dur-
ing pregnancy and postpartum in rural Vietnam.
Methods
Study context, design and participants
The study design, trial profile, and characteristics of the
study sample have been described in detail elsewhere
[16]. Briefly, 5011 married women aged 18–40 years
who were planning to become pregnant in the next year
were recruited from 20 communes in Thai Nguyen, a
northern mountainous province of Vietnam.
All eligible women were randomly assigned to one of
three pre-pregnancy groups for weekly supplementation
of: 1) folic acid (FA, 2800 μg – control), 2) iron and folic
acid (IFA, 2800 μg FA+ 60 mg iron) or 3) multiple micro-
nutrients (MM, 15 micronutrients including 2800 μg FA+
60 mg iron). The micronutrient composition of the sup-
plements is shown in Additional file 1. Village health
workers (VHWs) visited women every 2 weeks to deliver
the supplements. They directly observed the consumption
of one supplement during the home visit, and recorded
the number of supplements consumed and any symptoms
or side effects women may have since the last visit. They
also verified the supplement packets stored at women’s
homes and counted the number of remaining capsules.
Compliance was calculated as the percentage of number
of supplements consumed over the total number of sup-
plements delivered. VHWs also asked women whether
they had their menses since the last visit. Women who re-
ported their last menstrual period to be >5 weeks were in-
vited to the Commune Health Center (CHC) for a
pregnancy test. Once women were confirmed as pregnant,
they stopped weekly supplementation and started receiv-
ing supplements containing 60 mg of iron and 400 μg of
FA that were consumed daily through delivery as recom-
mended by the World Health Organization [17]. These
women were scheduled for prenatal and postpartum visits
at the CHC. All investigators, study personnel and partici-
pants were blinded to group assignment.
Sample size estimations
The sample size calculations were based on the primary
study outcomes (birth weight). Using a one tailed test of
comparing means between any two groups, we had esti-
mated that a minimum sample of 550 infants per group
(1650 total) was needed to detect an effect size of 0.15 SD
units or greater (60 g for birth weight) at a level of signifi-
cance of 0.05 and 80% power. [18]. This sample size has at
least 80% power to detect the difference of 0.5 scores in
depressive symptoms during pregnancy or postpartum.
Randomization and blinding
A list of all WRA was obtained from the CHC for each
commune. VHWs visited the homes of all married non-
pregnant women and invited those who were planning to
become pregnant within the next year to participate in the
screening. Women who were pregnant, had consumed IFA
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or MM supplements in the previous 2 months, were se-
verely anemic (Hb < 7 g/L), or had a history of high risk
pregnancy or chronic hematological diseases were not in-
cluded in the study. Women with severe anemia were re-
ferred to the local health clinic for treatment and those
with moderate and mild anemia were counselled about
risks associated with pregnancy and anemia. Upon confirm-
ation of eligibility, lists of the ID numbers of eligible women
were used to generate a randomization code to assign
women to one of the supplement groups.
All investigators, study personnel and participants
were blinded to group assignment. All supplements were
in capsule form, identical in appearance and taste, and
coded with lot numbers at the factory that correspond
to one of the three treatment arms. The code allocations
were stored by two individuals not involved in the study
at TUMP and Emory University and were opened only
after completion of the trial.
Measurements
Assessment of symptoms of depression:
We assessed maternal depressive symptoms using the Cen-
ter for Epidemiologic Studies Depression Scale (CES-D)
[19] before conception (baseline), and the Edinburgh Post-
natal Depression Scale (EPDS) during pregnancy and at
3 months postpartum. During pregnancy, EPDS was ad-
ministered at each prenatal visit up to three times: the first
time was immediately after detecting pregnancy, normally
during the first trimester, and the following two measures
took place in the second and third trimesters of pregnancy.
The CES-D scale includes a 20-item checklist that mea-
sures symptoms of depression experienced over the past
week, including depressed mood, guilt, worthlessness, help-
lessness, hopelessness, psychomotor retardation, loss of ap-
petite, and sleep disturbance. Each question is scored on a
scale of 0–3, yielding a range of possible scores from 0 to
60, with higher scores indicating increased severity of de-
pressive symptoms. Several studies have adapted this in-
strument for use with a variety of populations [20, 21],
including the Vietnamese population [22] and have con-
firmed its high validity and reliability. Baseline CES-D
scores were categorized into tertiles (high, medium, and
low) because very few women had values >16 which has
been used in previous studies as a cut-off to be indicative of
depression [19]. This allowed us to identify women with
higher levels of symptoms relative to the other women
within this sample of women.
The EPDS is a 10-item self-rating questionnaire that
addresses symptoms of depression present in the last 7
days [23]. Each question has four alternative answers
scoring 0 to 3, for a maximum score of 30; higher scores
denote greater levels of depressive symptomatology. The
EPDS has been used extensively to assess maternal men-
tal health both during pregnancy and postpartum and
has been used previously in Vietnam [24]. Symptoms of
depression during pregnancy and postpartum were re-
ported both as continuous outcomes (mean ± SD) of
EPDS and as the proportion of women with high risk of
maternal depressive symptoms (MDS), defined as EPDS
score ≥ 4. This cut-off was selected based on previous
work in Vietnam, where it was validated as a screening
tool (with sensitivity 70%; specificity 73%) [25] and was
predictive of infant motor development [24].
Both scales were translated into Vietnamese and
checked for accuracy through back translation and pilot
testing. The adaptation and administration of both these
instruments were reviewed by the study psychologist
(ADG) who has experience in using measures of depres-
sion in other studies [26, 27]. Both instruments were
interviewer-administered. Interviewers were trained on
the protection of interviewee privacy and data confiden-
tiality. All interviews were conducted in private.
Biochemical indicators of micronutrient status:
A finger-prick capillary blood sample was obtained to
measure hemoglobin (Hb) concentrations using a B-
Hemoglobin analyzer (Hemocue). Venous blood samples
were collected after overnight fasting at baseline, first pre-
natal visit and 3 months post-partum to measure iron store
(plasma ferritin) using the sandwich ELISA technique [28].
Other characteristics
Participants were interviewed at baseline (before concep-
tion) to gather information on their demographic charac-
teristics, level of education, current marital status,
reproductive history, and health status [16]. Socio-
economic status (SES) was created by principal compo-
nents analysis [29] using a set of questions related to own-
ership of property and land, household assets, housing
conditions, and access to utilities. Dietary intakes were col-
lected at baseline using a semi-quantitative food frequency
questionnaire developed by the Vietnam National Institute
of Nutrition. This food frequency questionnaire was vali-
dated with Vietnamese adults [30]. Body weight and height
were measured to the nearest 0.1 kg or 0.1 cm, respect-
ively, and body mass index (BMI) was calculated as weight
in kg over height in squared meters. All interviewers were
well-trained in interviewing techniques, ethical issues and
administration of the questionnaires.
Statistical analysis
We first analyzed the outcomes using an intention-to-treat
approach, followed by per protocol comparisons that re-
stricted the analytic sample to women who had received at
least 26 weeks of the preconceptional intervention. Propor-
tions, means, and SDs were presented for selected baseline
variables and compared between groups using ANOVA for
continuous variables and chi-square tests for proportions.
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We examined the distributions of the CES-D and EPDS
scores and compared mean values using ANOVA. We also
conducted stratified analyses by selected baseline character-
istics that had been chosen a-priori (preconception depres-
sive symptoms, anemia, and maternal undernutrition-
BMI < 18.5 kg/m2) using generalized linear models with
Hosmer-Lemeshow goodness of fit test. Data analysis was
performed using STATA 13.
Results
Among 5011 women randomized for inclusion into the
study, 1813 women became pregnant and contributed
1639 live births. Intent to treat analyses were conducted
for 1616 women who had at least one depression meas-
urement during pregnancy and 1465 women with data for
postpartum depression (Fig. 1). Selected baseline charac-
teristics including age, education, occupation, SES, dietary
intakes, anthropometric measurements, and biochemical
indicators were not significantly different across the three
treatment groups (Table 1). Women were on average
26 years old and over 90% already had one child. Nearly a
third were underweight (BMI <18.5 kg/m2), 20% had
anemia, and 14% had depleted iron stores at baseline.
Comparison of baseline characteristics also revealed no
differences between women who had EPDS data available
versus those who did not (results not shown). As reported
previously, compliance was over 90% for both preconcep-
tion and prenatal supplements and did not differ by treat-
ment group [31]. The average duration of consumption of
supplements before conception was 56 ± 28 weeks
(ranged: 2–107 weeks). There were also no differences
among the three groups in measures of weight and anemia
at the first and second prenatal visit (result not shown).
Preconceptional (baseline) mean CES-D score was
3.48 ± 4.71 and was similar across the three groups.
Mean EPDS scores during pregnancy was 1.5 ± 2.7,
1.1 ± 2.4, 0.7 ± 2.0 at first, second and third trimesters,
respectively, and 0.6 ± 1.8 during the early postpartum
period. The proportion of women ever experiencing ele-
vated MDS during pregnancy was 11.3%, 8.1% and 4.9%
at first, second and third trimesters, respectively, and
3.6% during the early postpartum period. We found no
significant differences by treatment group for mean
EPDS scores or prevalence of elevated MDS during
pregnancy and 3-months postpartum (Table 2). The per-
protocol analysis also showed no differences in elevated
MDS by treatment group in the subgroup of women
who received the supplement for at least 26 weeks be-
fore conception (results not shown).
The results of stratified analyses showed differential im-
pact of the intervention on EPDS scores during pregnancy
by baseline depression status. Among women in the high-
est tertile for CES-D scores at baseline, mean EPDS scores
were significantly lower in the first (MM:2.34, IFA:1.45,
FA: 2.88) and second trimester (MM:1.21, IFA: 1.27,
FA:2.06) of pregnancy in the MM and IFA groups com-
pared to FA only (P < 0.05) (Figure 2). In contrast, there
was no difference by treatment group on the risk of MDS
during the postpartum period. There were also no differ-
ences by treatment group by maternal underweight or
anemia (results not shown) for mean EPDS or risk of ele-
vated MDS during pregnancy or the post-partum period.
Discussion
In this large randomized controlled trial, we found no
main effect of weekly preconceptional supplementation
with MM or IFA compared to FA on prenatal and post-
partum depressive symptoms among women of repro-
ductive age from northern Vietnam. These findings were
the same for the per-protocol analysis, which included
women who consumed the supplements for at least
6 months prior to conception. Iron deficiency and
anemia have been associated with fatigue [32, 33] and
increased post-partum depressive symptoms [12], and it



















Fig. 1 Flow diagram of participant progress throughout the study. EPDS - Edinburgh Postnatal Depression Scale, FA - folic acid, IFA - iron and
folic acid, MM - Multiple micronutrient
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is possible that prenatal IFA supplements, which were
received by all women after conception, may have bene-
fited all women. The lack of differences by intervention
groups in weight or anemia both during pregnancy and
early post-partum also suggest possible attenuation of
the preconception intervention. We have also shown
that iron status was better during early pregnancy in the
MM and IFA group compared to FA only, but there
were no differences in maternal iron status at 3 months
post-partum or in cord blood ferritin [34]. Finally, the








Age at randomization, y 26.1 ± 4.6 25.9 ± 4.2 25.8 ± 4.2 0.49
Age at first married, y 21.7 ± 3.2 21.8 ± 3.3 21.9 ± 3.3 0.70
Ethnic minority, % 52.8 48.9 48.4 0.29
Education Level, %
Primary school 9.5 7.2 7.5 0.34
Secondary school 52.7 53.0 55.4
High school 27.4 26.6 23.4
College or higher 10.4 13.1 13.6
Work as farmers, % 82.0 78.1 78.0 0.18
SES index −0.01 ± 0.93 0.06 ± 0.95 0.06 ± 0.95 0.48
Number of children, %
0 5.1 5.9 5.5 0.84
1 93.3 92.7 93.7
≥ 2 1.6 1.3 0.8
Anthropometric measurements
Height, cm 152.7 ± 4.9 152.6 ± 5.0 152.8 ± 5.2 0.75
Weight, kg 46.1 ± 5.7 45.4 ± 5.1 45.8 ± 5.5 0.13
BMI, kg/m2 19.8 ± 2.1 19.5 ± 1.9 19.6 ± 2.1 0.10
Underweight (BMI < 18.5), % 29.0 31.5 32.2 0.50
Dietary intake /d
Total energy, kcal 2240 ± 775 2249 ± 754 2183 ± 711 0.29
Iron, mg 17.3 ± 8.1 17.7 ± 7.5 17.0 ± 8.1 0.35
Zinc, mg 10.6 ± 3.6 10.6 ± 3.5 10.3 ± 3.6 0.19
Vitamin C, mg 235 ± 158 244 ± 145 245 ± 199 0.53
Folate, μg 344 ± 210 355 ± 190 343 ± 193 0.53
Vitamin B12, μg 2.1 ± 2.3 2.0 ± 1.7 1.9 ± 1.8 0.18
Vitamin A, μg 440.2 ± 496.9 424.3 ± 360.1 414.8 ± 379.8 0.60
Hematological indicators
Hemoglobin, g/dL 12.9 ± 1.4 12.9 ± 1.4 13.0 ± 1.3 0.19
Anemia (Hb <12 g/dL), % 21.6 20.1 17.9 0.31
Ferritin, μg/L (geometric mean)d 66.31 64.07 66.89 0.74
Insufficient iron stores (ferritin <30 μg/L), % 13.5 14.6 11.1 0.20
Compliance to preconception supplementse 95.5 ± 9.7 96.1 ± 8.7 95.7 ± 9.4 0.19
Compliance for prenatal supplementse 97.1 ± 9.1 97.7 ± 6.9 97.7 ± 7.1 0.27
aSample sizes for each variable vary slightly due to item-specific missing data
bValues are mean ± SD or percentages unless otherwise noted
cANOVA test for comparison of means and goodness of fit test for comparison of proportions
dFerritin values were adjusted for inflammation indicators
eCompliance was calculated as the percentage of number of supplements consumed over the total number of supplements delivered
AGP alpha-1-acid glycoprotein, CRP C- reactive protein. BMI Body Mass Index, FA Folic acid, IFA Iron and folic acid, MM Multiple micronutrient, SES Social Economic
Status, RBP Retinol Binding Protein
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lack of differences may be also due to the fact that all
groups received FA which has been shown to reduce de-
pressive symptoms [35].
However, we found evidence of selective effects among
women at risk for depression before conception: among
women in the highest tertile of CES-D scores at baseline,
women who received MM or IFA before conception had
lower mean EPDS scores in the first and second trimesters
of pregnancy compared to those who received only FA.
These differences were statistically significant (p < 0.05).
However, the difference is small and may not be clinically
significant. Various micronutrients, such as vitamin D, sel-
enium, zinc, vitamin B12, folates and other B vitamins,
have been suggested as important for the prevention of
maternal depression [36]. Since iron and folic acid were
common to both MM and IFA, and all groups received
FA, we assume that iron was the key element explaining
the results, but the mechanisms are unclear since we did
not find differential effects of the intervention by baseline
iron status or anemia, and the effect of MM and IFA sup-
plements among those at-risk for depression at baseline
was not observed during the postpartum period. While
previous studies have shown an association between iron
status and maternal depression postpartum [11, 12], a re-
cent study in China reported only small correlations be-
tween iron status throughout pregnancy and postpartum
depressive symptoms measured using EPDS [37].
Prevalence of elevated MDS decreased significantly as
pregnancy progressed, and was even lower during the
early postpartum period. This pattern is consistent with
the other study in Vietnam using a similar cut-off; how-
ever, the prevalence of high depressive symptoms during
pregnancy was lower compared to this previous study
[24] (~11% vs. 40% in early and 5% vs. 28% in late preg-
nancy), and much lower (~ 3%) when using a standard
cut-off (EPDS > 10) than what has been reported in low
and middle income countries (16%) [38]. In addition, in
this cohort, the prevalence of high depressive symptoms
was very low in the post-partum period. It is estimated
that post-partum depression ranges between 10 and 15%
worldwide [39]. However, country-specific variation has
been reported, with some countries such as Singapore,
Malta, Malaysia, Austria and Denmark reporting almost
no postpartum-depression and others including Brazil,
Costa Rica, Taiwan and Korea reporting a high preva-
lence of up to 60% [39]. One study from Vietnam re-
ported a prevalence of 33% for depression at 6 weeks
postpartum in an urban population/hospital setting from
Ho-Chi-Min City [40]. This contrasts with the extremely
low prevalence of ~1% in our cohort at 3 months post-
partum if using the standard cut-off (EPDS > 10). The
differences may be due in part to our study selection cri-
teria and timing of measurement; we included only mar-
ried women who clearly expressed their intention to
become pregnant, and women with planned pregnancies
have been shown to have lower rates of postpartum de-
pression compared to those with unplanned pregnancies
[41]. Additionally, our study was conducted in a more
rural population and reporting of depressive symptoms
might be different between urban and rural women.
Strengths of this study include the large sample size, the
extensive follow-up from preconception through pregnancy
and delivery, the randomized controlled trial design, the
double blinding to the intervention of participants and the
research team, and the extensive data collection on socio-
demographic, physiological, and mental health variables at
Table 2 Mean depression scores and proportion of women at risk of elevated depressive symptoms from preconception to









Preconception CESD 3.42 ± 4.58 3.33 ± 4.13 3.66 ± 5.30 0.48
Prenatal EPDS (first trimester) 1.43 ± 2.57 1.32 ± 2.43 1.62 ± 3.03 0.15
Prenatal EPDS (second trimester) 1.03 ± 2.30 1.15 ± 2.38 1.18 ± 2.46 0.69
Prenatal EPDS (third trimester) 0.71 ± 1.94 0.61 ± 1.85 0.87 ± 2.16 0.20
Postpartum EPDS (3 mo) 0.65 ± 1.91 0.56 ± 1.57 0.59 ± 1.98 0.72
Proportion who reported elevated MDS during pregnancy
Prenatal (first trimester) 11.00 9.32 13.29 0.11
Prenatal (second trimester) 7.42 8.94 8.04 0.68
Prenatal (third trimester) 6.08 3.11 5.29 0.16
Postpartum (3 mo) 4.45 3.32 0.31 0.49
aSample sizes for each variable vary slightly due to item-specific missing data.
bValues are mean ± SD or percentages unless otherwise noted
cANOVA test for comparison of means and goodness of fit test for comparison of proportions
CESD Center for Epidemiologic Studies Depression Scale, EPDS Edinburgh Postnatal Depression Scale, FA Folic acid, IFA Iron and folic acid, MDS Maternal
depressive symptoms, MM Multiple micronutrient
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different time points. The field personnel were extensively
trained and procedures were standardized to assure high
quality data-collection. To our knowledge, this is the first
study to assess the impact of preconceptional micronutrient
supplementation on maternal depressive symptoms during
pregnancy and after delivery. Conversely, limitations of this
study include the lack of biomarkers of micronutrient sta-
tus except for iron. Although we have information on
underweight and dietary quality, these may be imperfect
proxies to account for possible differences. We also did not
measure perceived level of social and/or emotional support
by these women which may be associated with depressive
symptoms [42]. Our population was unique in the low-
prevalence of iron-deficiency and postpartum depression;
thus our results might not be generalizable to other popula-
tions where these two factors are of greater concern. As
mentioned before, women enrolled in this study were
highly motivated to get pregnant, which might also affect
the generalizability of our findings to other populations at
higher risk of post-partum depression.
Conclusion
Weekly preconceptional micronutrient supplements con-
taining iron did not improve depression measures relative
to folic acid alone among all women, but may have benefit-
ted women who were at risk for depression. However, the
mechanisms are unclear, and they may have been due to
chance especially since we did not see any interactions by
baseline markers of iron status. Future studies are needed
to evaluate the benefits of providing preconceptional mul-
tiple micronutrient supplements in other populations with
greater prevalence of iron-deficiency and/or maternal de-
pression and the optimal package of services that is needed
to promote the health and wellbeing of women of repro-
ductive age.
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Fig. 2 Mean EPDS score during pregnancy and postpartum, by
treatment group and baseline level of depressive symptoms1,2.
a Low tertile CESD score (n = 725), (b) Middle tertile CESD
score (n = 468), (c) High tertile CESD score (n = 423).
1P = 0.001 and 0.047 for interaction between treatment group
and high tertile level of depressive symptoms for mean EPDS
score at first and second trimester, respectively 2. Baseline
CESD score: low tertile: score 0–1, middle tertile: score 2–4.
High tertile: score 5–46.CESD Center for Epidemiologic Studies
Depression Scale, EPDS Edinburgh Postnatal Depression
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